Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02396134
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:47.413088+00:00
Published At
2023-07-12T00:00:00+00:00
Record Updated At
2025-03-03
Results Posted At
2023-07-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "Adult Hodgkin Lymphoma", "Adult Non-Hodgkin Lymphoma", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Cytomegaloviral Infection", "Hematopoietic and Lymphoid Cell Neoplasm", "HLA-A*0201 Positive Cells Present", "Myelodysplastic Syndrome", "Adult Lymphoblastic Lymphoma", "Chronic Lymphocytic Leukemia", "Myelofibrosis", "Myeloproliferative Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-03"
protocolSection.identificationModule.nctId
"NCT02396134"
protocolSection.identificationModule.officialTitle
"A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-07-12"

Study condition terms

  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Adult Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Adult Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Cytomegaloviral Infection (protocolSection.conditionsModule.conditions)
  • Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • HLA-A*0201 Positive Cells Present (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.